Swiss National Bank Has $11.83 Million Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Swiss National Bank increased its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 2.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 221,600 shares of the company's stock after buying an additional 5,400 shares during the quarter. Swiss National Bank owned 0.12% of Doximity worth $11,831,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of DOCS. FMR LLC grew its stake in Doximity by 30.5% during the third quarter. FMR LLC now owns 6,837,733 shares of the company's stock worth $297,920,000 after buying an additional 1,598,602 shares during the last quarter. State Street Corp boosted its holdings in shares of Doximity by 2.5% in the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company's stock worth $160,947,000 after acquiring an additional 88,922 shares in the last quarter. Geode Capital Management LLC grew its position in Doximity by 19.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock worth $124,503,000 after acquiring an additional 472,565 shares during the last quarter. Los Angeles Capital Management LLC increased its holdings in Doximity by 33.7% during the 4th quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company's stock valued at $46,466,000 after purchasing an additional 219,448 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in Doximity by 3.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 778,524 shares of the company's stock valued at $41,565,000 after purchasing an additional 25,523 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Remove Ads

Insiders Place Their Bets

In other news, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 37.40% of the company's stock.

Doximity Stock Up 5.4 %

Doximity stock traded up $3.40 during midday trading on Monday, hitting $66.39. 3,877,737 shares of the stock were exchanged, compared to its average volume of 1,891,424. The stock has a market capitalization of $12.39 billion, a PE ratio of 66.39, a P/E/G ratio of 4.10 and a beta of 1.34. The company has a fifty day simple moving average of $64.42 and a two-hundred day simple moving average of $53.63. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21.

Analysts Set New Price Targets

Several analysts have recently commented on the company. The Goldman Sachs Group increased their target price on Doximity from $58.00 to $80.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Piper Sandler raised shares of Doximity from a "neutral" rating to an "overweight" rating and increased their price objective for the stock from $31.00 to $78.00 in a report on Friday, February 7th. Stephens assumed coverage on shares of Doximity in a research note on Friday, December 20th. They issued an "equal weight" rating and a $55.00 target price for the company. Raymond James reissued an "outperform" rating and set a $83.00 price target (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. Finally, Mizuho boosted their price objective on shares of Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.